GlaxoSmithKline to buy San Mateo-based Sierra Oncology for $1.9B By: Silicon Valley Business Journal via Business Journals April 13, 2022 at 10:31 AM EDT Glaxo is paying a 39% premium for the rare cancer-focused biotech whose stock has already shot up 82% this year. Read More >>
